K.Y. Jung’s research while affiliated with Seoul National University Bundang Hospital and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (3)


Age- and sex-specific association of circulating osteocalcin with dynamic measures of glucose homeostasis
  • Article

September 2015

·

40 Reads

·

30 Citations

Osteoporosis International

K. Y. Jung

·

K. M. Kim

·

·

[...]

·

Our study showed that serum osteocalcin levels are closely related to glucose metabolism in men of all ages and younger women. This association disappeared in postmenopausal women in which increases bone turnover rates. The association between serum osteocalcin levels and glucose homeostasis should be interpreted according to age and sex. Introduction: Osteocalcin, a marker of bone formation, appears to be associated with glucose homeostasis. We investigated the age- and sex-specific association of serum osteocalcin level with variables related to glucose metabolism. Methods: This study was based on cross-sectional analysis from 719 participants aged 20-85 years after excluding patients taking antidiabetic or antiosteoporotic drugs. The subjects were divided into four groups according to age and sex as follows: men <50 years (n = 131), men ≥50 years (n = 191), women <50 years (n = 108), and women ≥50 years (n = 279). Anthropometric and biochemical variables including insulin resistance (HOMA-IR) and β cell function (HOMA-β) from a 75-g oral glucose tolerance test, and serum 25-OH-vitamin D and parathyroid hormone levels were measured. Results: The serum osteocalcin level was significantly higher in women aged ≥50 years compared with women <50 years (20.4 ± 7.8 vs. 17.9 ± 6.8 ng/ml, p < 0.001), but there was no difference between men aged ≥50 years and men <50 years (16.4 ± 5.9 vs. 16.8 ± 6.0 ng/ml, p = 0.905). The participants diagnosed with diabetes had lower serum osteocalcin levels than normal or prediabetic participants. Multivariable regression analyses including HOMA-IR and HOMA-β indicated that serum osteocalcin levels had a negative and independent association with HbA1c levels in men and women aged <50 years, but not in women ≥50 years. Conclusions: Low osteocalcin levels are associated with impaired glucose metabolism in men and premenopausal women. The osteocalcin levels may be determined by factors related to bone metabolism in postmenopausal women. Our data suggest that the serum levels of osteocalcin associated with glucose homeostasis should be interpreted according to age and sex.



Citations (2)


... Considering the > 5 years median follow-up period in this study, we believe that the reduced risk of diabetes in hip fracture patients observed in this study was likely contributed to by a difference in BMD when compared with the control group, which were fall patients without hip fractures. Previous cross-sectional studies showed inverse associations of bone turnover markers (BTMs) with fasting glucose [10,19], HbA1c [10,20], and HOMA-IR [21]. Increased bone turnover is responsible for rapid bone loss in age-related and post-menopausal osteoporosis. ...

Reference:

Hip fracture is associated with a reduced risk of type 2 diabetes: A retrospective cohort study
Age- and sex-specific association of circulating osteocalcin with dynamic measures of glucose homeostasis
  • Citing Article
  • September 2015

Osteoporosis International

... This three-step optional combination may be useful in treating diabetes in obese subjects. Sitagliptin is an orally active inhibitor of DPP-4, with a fully reversible action [7]. It increases glucose-dependent insulin secretion, while decreasing glucagon secretion and hepatic glucose production. ...

PO182 FOUR YEAR OUTCOME OF INITIAL COMBINATION OF SITAGLIPTIN AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN REAL CLINICAL PRACTICE
  • Citing Article
  • November 2014

Diabetes Research and Clinical Practice